TERT and meningioma: Although smaller cohort studies have suggested that TP53 is not likely to be involved in the aetiology of meningioma, a recent study on a large cohort of 850 high-grade/progressive meningiomas identified a group of meningiomas with poor prognosis characterised by TERT promoter or TP53 mutations [37].